Skip to main content
Clinical Trials/ISRCTN39435140
ISRCTN39435140
Terminated
未知

The metabolic consequences of gastrointestinal surgery

Cambridge University Hospitals NHS Foundation Trust0 sites200 target enrollmentFebruary 3, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Enrollment
200
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2017
End Date
October 1, 2021
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 years and over
  • 2\. Capacity to give voluntary informed consent
  • 3\. Undergone, or have planned within the next 12 months, surgery including removal of all or part of the stomach or oesophagus; or be a carrier of a genetic mutation conferring a high risk of requiring a future prophylactic gastrectomy

Exclusion Criteria

  • All participants:
  • 1\. Aged under 18 years
  • 2\. Recent history of untreated anaemia
  • 3\. Lack capacity to read and retain information about the study
  • 4\. Communication issues which prevent accurate understanding of the study rationale and requirements
  • Post\-operative participants:
  • 1\. Recurrent gastric or oesophageal cancer
  • Participants for endoscopy:
  • 1\. Contraindication to upper gastrointestinal endoscopy
  • 2\. Taking medication that would pose a significant risk of haemorrhage after biopsy (e.g. Clopidogrel, Warfarin, Dipyridamole, novel oral antigoagulants, therapeutic dose heparin)

Outcomes

Primary Outcomes

Not specified

Similar Trials